News | October 06, 2014

St. Elizabeth Healthcare Study Shows Toshiba’s Smart Fusion Delivers Accurate Ultrasound-Guided Biopsies at Less Cost

More efficient and precise exams improve the patient experience

October 6, 2014 — A prospective clinical evaluation at St. Elizabeth Healthcare showed that Toshiba America Medical Systems Inc.’s Smart Fusion ultrasound technology gives clinicians a worry-free experience, delivering safer and more accurate guidance for liver and kidney lesion biopsies. Out of 35 biopsies observed, the technology successfully sampled the lesion of interest in 34 cases (more than 97 percent). A separate cost-benefit analysis showed St. Elizabeth Healthcare saves approximately $85,000 annually by utilizing Smart Fusion.

The evaluation set out to assess the clinical efficacy of ultrasound-guided liver and kidney biopsies using Smart Fusion. Available on the Aplio 500 ultrasound system, Smart Fusion allows physicians to fuse live ultrasound with previously acquired computed tomography (CT) or magnetic resonance (MR) images and display simultaneously.

The study evaluated a total of 35 patients undergoing ultrasound-guided biopsies using Smart Fusion between February 2013 and May 2014, including 33 liver lesion biopsies, one renal core biopsy and one renal lesion biopsy. In addition to clinical accuracy, shorter procedure times, less radiation exposure and the absence of invasive surgical biopsies contributed to a higher rate of patient satisfaction.

“The ability to view previously acquired CT or MR scans with live ultrasound using Smart Fusion provides significant benefit to both clinicians and patients,” said Van Young, M.D., interventional radiologist, Radiology Associates of Northern Kentucky, PLLC, and St. Elizabeth Healthcare. “The patient receives a less invasive, accurate biopsy, while the physician can perform confident biopsies, especially with difficult lesions. Both see a benefit in the reduced cost of the procedure.”

“Our work with St. Elizabeth Healthcare and its success with the Smart Fusion technology exemplify Toshiba’s commitment to providing customers with a worry free experience,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “As healthcare reform calls for improvements in quality of care and efficient use of resources, technologies like Smart Fusion will help providers to both increase the standard of care and minimize financial impacts for all parties.”

For more information: www.toshibamedicalsystems.com.

Related Content

Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty
News | Cardiovascular Ultrasound | August 05, 2019
A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ambulatory...
Studies Confirm Clinical Value of ShearWave Elastography for Liver Fibrosis Evaluation
News | Ultrasound Imaging | July 31, 2019
SuperSonic Imagine announced the publication of the results of its prospective multicentric clinical study conducted in...
Intelligent Ultrasound Group Collaborating With the National Imaging Academy Wales

The ScanTrainer transvaginal simulator is one example of Intelligent Ultrasound's simulation technologies.

News | Ultrasound Imaging | July 26, 2019
Artificial intelligence (AI)-based ultrasound software and simulation company Intelligent Ultrasound Group plc (AIM:...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...